Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP19803.RAJ_P51OE8vELkAwdjitWdy4Y28ZBHnIisiFqL6JH5sjY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP19803.RAJ_P51OE8vELkAwdjitWdy4Y28ZBHnIisiFqL6JH5sjY130_assertion type Assertion NP19803.RAJ_P51OE8vELkAwdjitWdy4Y28ZBHnIisiFqL6JH5sjY130_head.
- NP19803.RAJ_P51OE8vELkAwdjitWdy4Y28ZBHnIisiFqL6JH5sjY130_assertion description "[We demonstrate the clinical usefulness of a panel of beta2 integrins (CD11a, CD11b and CD11c) in accurate prediction of AML-M3, and recommend inclusion of this immunophenotypic analysis to identify patients who require ATRA therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP19803.RAJ_P51OE8vELkAwdjitWdy4Y28ZBHnIisiFqL6JH5sjY130_provenance.
- NP19803.RAJ_P51OE8vELkAwdjitWdy4Y28ZBHnIisiFqL6JH5sjY130_assertion evidence source_evidence_curated NP19803.RAJ_P51OE8vELkAwdjitWdy4Y28ZBHnIisiFqL6JH5sjY130_provenance.
- NP19803.RAJ_P51OE8vELkAwdjitWdy4Y28ZBHnIisiFqL6JH5sjY130_assertion SIO_000772 16764927 NP19803.RAJ_P51OE8vELkAwdjitWdy4Y28ZBHnIisiFqL6JH5sjY130_provenance.
- NP19803.RAJ_P51OE8vELkAwdjitWdy4Y28ZBHnIisiFqL6JH5sjY130_assertion wasDerivedFrom ctd_human-20150221 NP19803.RAJ_P51OE8vELkAwdjitWdy4Y28ZBHnIisiFqL6JH5sjY130_provenance.
- NP19803.RAJ_P51OE8vELkAwdjitWdy4Y28ZBHnIisiFqL6JH5sjY130_assertion wasGeneratedBy ECO_0000218 NP19803.RAJ_P51OE8vELkAwdjitWdy4Y28ZBHnIisiFqL6JH5sjY130_provenance.